Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Journal of Diabetes Research
Volume 2015, Article ID 932057, 6 pages
http://dx.doi.org/10.1155/2015/932057
Research Article

Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population

1Department of Internal Medicine, Iida Municipal Hospital, 438 Yawata-machi, Iida, Nagano 395-8502, Japan
2Division of Companion Diagnostics, Department of Pathology of Microbiology, Nihon University School of Medicine, 30-1 Ooyaguchi-kamimachi, Itabashi-ku, Tokyo 173-8610, Japan

Received 12 March 2015; Accepted 18 May 2015

Academic Editor: Abdelaziz Amrani

Copyright © 2015 Masanori Shimodaira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Google Scholar
  2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. G. Tabák, C. Herder, W. Rathmann, E. J. Brunner, and M. Kivimäki, “Prediabetes: a high-risk state for diabetes development,” The Lancet, vol. 379, no. 9833, pp. 2279–2290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Eschwège, M. A. Charles, D. Simon, N. Thibult, and B. Balkau, “Reproducibilily of the diagnosis of diabetes over a 30-month follow-up: the Paris prospective study,” Diabetes Care, vol. 24, no. 11, pp. 1941–1944, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Drzewoski and L. Czupryniak, “Concordance between fasting and 2-h post-glucose challenge criteria for the diagnosis of diabetes mellitus and glucose intolerance in high risk individuals,” Diabetic Medicine, vol. 18, no. 1, pp. 29–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. International Expert Committee, “International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1327–1334, 2009. View at Google Scholar
  7. American Diabetes Association, “Standards of medical care in diabetes—2010,” Diabetes Care, vol. 33, supplement 1, pp. S11–S61, 2009. View at Publisher · View at Google Scholar
  8. W. H. Herman, Y. Ma, G. Uwaifo et al., “Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program,” Diabetes Care, vol. 30, no. 10, pp. 2453–2457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. H. Herman, K. M. Dungan, B. H. R. Wolffenbuttel et al., “Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 5, pp. 1689–1694, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. C. Ziemer, P. Kolm, W. S. Weintraub et al., “Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies,” Annals of Internal Medicine, vol. 152, no. 12, pp. 770–777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. American Diabetes Association, “Standards of medical care in diabetes—2014,” Diabetes Care, vol. 37, supplement 1, pp. S14–S80, 2014. View at Publisher · View at Google Scholar
  12. S. Matsuo, E. Imai, M. Horio et al., “Revised equations for estimated GFR from serum creatinine in Japan,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 982–992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Goodall, P. G. Colman, H. G. Schneider, M. McLean, and G. Barker, “Desirable performance standards for HbA1c analysis-precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA),” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 8, pp. 1083–1097, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Hanley and B. J. McNeil, “The meaning and use of the area under a receiver operating characteristic (ROC) curve,” Radiology, vol. 143, no. 1, pp. 29–36, 1982. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Viera and J. M. Garrett, “Understanding interobserver agreement: the kappa statistic,” Family Medicine, vol. 37, no. 5, pp. 360–363, 2005. View at Google Scholar · View at Scopus
  16. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2009. View at Publisher · View at Google Scholar
  17. C. D. Saudek, W. H. Herman, D. B. Sacks, R. M. Bergenstal, D. Edelman, and M. B. Davidson, “A new look at screening and diagnosing diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2447–2453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Colagiuri, Z. Hussain, P. Zimmet, and A. Cameron, “Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience,” Diabetes Care, vol. 27, no. 2, pp. 367–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Rohlfing, R. R. Little, and H. M. Wiedmeyer, “Use of GHb HbA1c in screening for undiagnosed diabetes in the U.S. population,” Diabetes Care, vol. 23, no. 2, pp. 187–191, 2000. View at Publisher · View at Google Scholar
  20. G. T. C. Ko, J. C. N. Chan, V. T. F. Yeung et al., “Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects,” Diabetes Care, vol. 21, no. 8, pp. 1221–1225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Favier, I. Jaussent, N. Le Moullec et al., “Prevalence of Type 2 diabetes and central adiposity in La Réunion Island, the REDIA Study,” Diabetes Research and Clinical Practice, vol. 67, no. 3, pp. 234–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Inoue, M. Matsumoto, and Y. Kobayashi, “The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers,” Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. 451–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. M. Bennett, M. Guo, and S. C. Dharmage, “HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review,” Diabetic Medicine, vol. 24, no. 4, pp. 333–343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. X. H. Zhou, L. N. Ji, Y. Y. Luo, X. Y. Zhang, X. Y. Han, and Q. Qiao, “Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing,” Diabetic Medicine, vol. 26, no. 12, pp. 1262–1268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Lee, J.-Y. Oh, Y.-A. Sung et al., “Optimal hemoglobin A1C cutoff value for diagnosing type 2 diabetes mellitus in Korean adults,” Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 231–236, 2013. View at Publisher · View at Google Scholar · View at Scopus